Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 8.200
- -0.280-3.30%
Close Apr 29 16:00 ET
- 8.350
- +0.150+1.83%
Pre 05:30 ET
848.84MMarket Cap-1.56P/E (TTM)
8.640High8.155Low2.86MVolume8.570Open8.480Pre Close23.99MTurnover2.92%Turnover RatioLossP/E (Static)103.52MShares28.18052wk High0.97P/B802.89MFloat Cap5.90052wk Low--Dividend TTM97.91MShs Float202.730Historical High--Div YieldTTM5.72%Amplitude5.900Historical Low8.403Avg Price1Lot Size
About Intellia Therapeutics Company
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolNTLA
Company NameIntellia Therapeutics
Listing DateMay 6, 2016
Issue Price18.00
Founded2014
CEODr. John M. Leonard, M.D.
MarketNASDAQ
Employees403
Fiscal Year Ends12-31
Address40 Erie Street,Suite 130
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-857-285-6200
Websitehttp://www.intelliatx.com
Company Executives
- Name
- Position
- Salary
- Dr. John M. Leonard, M.D.
- Director, President and Chief Executive Officer
- 11.66M
- Eliana Clark
- Executive Vice President and Chief Technology Officer
- --
- Derek Hicks
- Executive Vice President and Chief Business Officer
- --
- Dr. David Lebwohl, M.D.
- Executive Vice President and Chief Medical Officer
- 4.26M
- Birgit Schultes
- Executive Vice President and Chief Scientific Officer
- --
- Michael P. Dube
- Vice President and Chief Accounting Officer
- --
- Edward J. Dulac, III
- Treasurer, Executive Vice President and Chief Financial Officer
- --
- James Basta, J.D.
- Executive Vice President, General Counsel and Corporate Secretary
- 3.99M
- Dr. Frank Verwiel, M.B.A.,M.D.
- Chairman of the Board
- 499.94K
- Muna Bhanji, Ph.
- Independent Director
- 455.25K
- William J. Chase
- Independent Director
- 996.21K
- Brian Goff
- Independent Director
- --
- Dr. Jesse Goodman, M.D.,M.P.H.
- Independent Director
- 449.94K
- Dr. Georgia Keresty, M.P.H.,PhD
- Independent Director
- 454.94K
- Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
- Independent Director
- 452.44K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now